After struggling in the years following its IPO, shares of gene sequencing specialist Pacific Biosciences of California (NASDAQ:PACB) jumped more than 70% yesterday after the company announced a multimillion-dollar deal with pharmaceutical company Roche (OTC:RHHBY). In the following video, from The Motley Fool's health-care show Market Checkup, analysts Max Macaluso and David Williamson discuss the deal.

Editor's note: This video was recorded on Sept. 25, 2013.